Allspring Global Investments
RXST icon

Allspring Global Investments’s RxSight RXST Stock Holding History

Allspring Global Investments’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-162,730
Closed -$8.04M – 2291
2024
Q3 		$8.04M Sell
162,730
-12,211
-7% -$626K 0.01% 830
2024
Q2 		$10.5M Sell
174,941
-12,412
-7% -$709K 0.02% 737
2024
Q1 		$9.66M Sell
187,353
-1,617
-0.9% -$79.4K 0.02% 777
2023
Q4 		$7.62M Sell
188,970
-54,376
-22% -$1.59M 0.01% 821
2023
Q3 		$6.79M Buy
243,346
+176,451
+264% +$5.26M 0.01% 864
2023
Q2 		$1.93M Buy
+66,895
New +$1.49M ﹤0.01% 1248
2022
Q2 		– Sell
-17,056
Closed -$211K – 2897
2022
Q1 		$211K Sell
17,056
-6,340
-27% -$76.1K ﹤0.01% 2559
2021
Q4 		$263K Buy
+23,396
New +$281K ﹤0.01% 2553

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Allspring Global Investments's RXST Position: Q4 2024 in Review

Allspring Global Investments sold out of RxSight (RXST) in Q4 2024, closing a stake of 162,730 shares — an estimated $8.04M sold.

Allspring Global Investments first reported a position in RXST in Q4 2021 and held it in 8 quarters. The position peaked at $10.5M in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Allspring Global Investments reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 162,730 RxSight shares in Q4 2024, an estimated $8.04M.
  • Allspring Global Investments first reported a position in RxSight in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's RxSight position peaked at $10.5M in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.